Tag
PG Electroplast Limited
5 articles
Regulatory scrutiny and operational disruptions are currently impacting PG Electroplast Limited. The company received a warning from SEBI regarding insider trading violations, though management asserts minimal financial or operational consequences and corrective actions have been taken. Simultaneously, a medical exigency involving a Key Managerial Personnel has led to the postponement of the Q4 FY26 investor meeting and rescheduling of board meetings, alongside an extended trading window closure for insiders. While the company has now rescheduled the earnings call and board meeting to discuss FY26 results and potential dividend recommendations, these events introduce uncertainty and may temporarily dampen investor sentiment, highlighting the importance of corporate governance and succession planning for the company.
PG Electroplast Receives SEBI Warning for Insider Trading
PG Electroplast received an administrative warning letter from SEBI dated May 15, 2026, regarding insider trading violations.
The warning concerns trades executed by certain Designated Persons in viol
PG Electroplast Withdraws Q4 FY26 Investor Meeting
PG Electroplast withdraws its scheduled investor meeting and earnings conference call for Q4 FY26 results due to a medical exigency affecting a Key Managerial Personnel.
The meeting, previously schedu
PG Electroplast Reschedules Board Meeting to May 27
PG Electroplast reschedules its board meeting to May 27, 2026, due to a medical exigency of a Key Managerial Personnel.
The meeting will consider and approve businesses originally slated for the previ
PG Electroplast Schedules Q4 FY26 Earnings Call
PG Electroplast officials will attend an earnings conference call on May 20, 2026, to discuss Q4 and FY26 financial results.
The meeting is organized by JM Financial and will feature Managing Director
PG Electroplast Board Meeting for FY26 Results, Dividend
PG Electroplast board meeting scheduled for May 19, 2026 to approve audited financial results for Q4 and FY ended March 31, 2026.
Board to consider recommendation of final dividend for financial year